Cargando…

Cholesterol Efflux Efficiency of Reconstituted HDL Is Affected by Nanoparticle Lipid Composition

Cardiovascular disease (CVD), the leading cause of mortality worldwide is primarily caused by atherosclerosis, which is promoted by the accumulation of low-density lipoproteins into the intima of large arteries. Multiple nanoparticles mimicking natural HDL (rHDL) have been designed to remove cholest...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jebari-Benslaiman, Shifa, Uribe, Kepa B., Benito-Vicente, Asier, Galicia-Garcia, Unai, Larrea-Sebal, Asier, Alloza, Iraide, Vandenbroeck, Koen, Ostolaza, Helena, Martín, César
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7598155/ https://www.ncbi.nlm.nih.gov/pubmed/32977626 http://dx.doi.org/10.3390/biomedicines8100373

Ejemplares similares

Pathophysiology of Atherosclerosis
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2022)

Predictive Modeling and Structure Analysis of Genetic Variants in Familial Hypercholesterolemia: Implications for Diagnosis and Protein Interaction Studies
por: Larrea-Sebal, Asier, et al.
Publicado: (2023)

Statin Treatment-Induced Development of Type 2 Diabetes: From Clinical Evidence to Mechanistic Insights
por: Galicia-Garcia, Unai, et al.
Publicado: (2020)

Pathophysiology of Type 2 Diabetes Mellitus
por: Galicia-Garcia, Unai, et al.
Publicado: (2020)

Familial Hypercholesterolemia: The Most Frequent Cholesterol Metabolism Disorder Caused Disease
por: Benito-Vicente, Asier, et al.
Publicado: (2018)

Cardiovascular Disease, Atherosclerosis and Familial Hypercholesterolemia: From Molecular Mechanisms Causing Pathogenicity to New Therapeutic Approaches
por: Jebari-Benslaiman, Shifa, et al.
Publicado: (2023)

MLb-LDLr: A Machine Learning Model for Predicting the Pathogenicity of LDLr Missense Variants
por: Larrea-Sebal, Asier, et al.
Publicado: (2021)

Mutation type classification and pathogenicity assignment of sixteen missense variants located in the EGF-precursor homology domain of the LDLR
por: Galicia-Garcia, Unai, et al.
Publicado: (2020)

Validation of LDLr Activity as a Tool to Improve Genetic Diagnosis of Familial Hypercholesterolemia: A Retrospective on Functional Characterization of LDLr Variants
por: Benito-Vicente, Asier, et al.
Publicado: (2018)

A Systematic Approach to Assess the Activity and Classification of PCSK9 Variants
por: Uribe, Kepa B., et al.
Publicado: (2021)

Functional Characterization of p.(Arg160Gln) PCSK9 Variant Accidentally Found in a Hypercholesterolemic Subject
por: Larrea-Sebal, Asier, et al.
Publicado: (2023)

miR-27b Modulates Insulin Signaling in Hepatocytes by Regulating Insulin Receptor Expression
por: Benito-Vicente, Asier, et al.
Publicado: (2020)

p.(Asp47Asn) and p.(Thr62Met): non deleterious LDL receptor missense variants functionally characterized in vitro
por: Benito-Vicente, A., et al.
Publicado: (2018)

Replacement of cysteine at position 46 in the first cysteine-rich repeat of the LDL receptor impairs apolipoprotein recognition
por: Benito-Vicente, A., et al.
Publicado: (2018)

Enhanced HDL Functionality in Small HDL Species Produced Upon Remodeling of HDL by Reconstituted HDL, CSL112: Effects on Cholesterol Efflux, Anti-Inflammatory and Antioxidative Activity
por: Didichenko, Svetlana A., et al.
Publicado: (2016)

Understanding the Mechanism of Translocation of Adenylate Cyclase Toxin across Biological Membranes
por: Ostolaza, Helena, et al.
Publicado: (2017)

Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
por: Daniil, Georgios, et al.
Publicado: (2013)

Correction: Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux
Publicado: (2014)

ApoCIII enrichment in HDL impairs HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2017)

Uremia alters HDL composition and cholesterol efflux capacity
por: Holzer, Michael, et al.
Publicado: (2012)

Nascent HDL (High-Density Lipoprotein) Discs Carry Cholesterol to HDL Spheres: Effects of HDL Particle Remodeling on Cholesterol Efflux
por: Navdaev, Alexei V., et al.
Publicado: (2020)

Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacity
por: Rubinow, Katya B., et al.
Publicado: (2012)

Pharmacological Targeting of the ER-Resident Chaperones GRP94 or Cyclophilin B Induces Secretion of IL-22 Binding Protein Isoform-1 (IL-22BPi1)
por: Gómez-Fernández, Paloma, et al.
Publicado: (2019)

Interactome of the Autoimmune Risk Protein ANKRD55
por: Ugidos, Nerea, et al.
Publicado: (2019)

Age, Origin and Functional Study of the Prevalent LDLR Mutation Causing Familial Hypercholesterolaemia in Gran Canaria
por: Suárez, Nicolás M., et al.
Publicado: (2023)

Lack of Correlation of Plasma HDL With Fecal Cholesterol and Plasma Cholesterol Efflux Capacity Suggests Importance of HDL Functionality in Attenuation of Atherosclerosis
por: Srivastava, Neelam, et al.
Publicado: (2018)

The negative effect of ANGPTL8 on HDL-mediated cholesterol efflux capacity
por: Luo, Mengdie, et al.
Publicado: (2018)

9-cis β-Carotene Increased Cholesterol Efflux to HDL in Macrophages
por: Bechor, Sapir, et al.
Publicado: (2016)

Lower than average HDL cholesterol efflux capacity in Lithuanian population
por: Kutkiene, Sandra, et al.
Publicado: (2019)

HDL cholesterol efflux capacity and lipid profile in patients with systemic sclerosis
por: Ferraz-Amaro, Iván, et al.
Publicado: (2021)

HDL Cholesterol Efflux and the Complement System Are Linked in Systemic Lupus Erythematosus
por: García-González, María, et al.
Publicado: (2023)

Human paraoxonase 1 overexpression in mice stimulates HDL cholesterol efflux and reverse cholesterol transport
por: Ikhlef, Souade, et al.
Publicado: (2017)

Effects of pre-eclampsia on HDL-mediated cholesterol efflux capacity after pregnancy
por: Kockx, Maaike, et al.
Publicado: (2022)

A Trifluoromethyl Analogue of Celecoxib Exerts Beneficial Effects in Neuroinflammation
por: Di Penta, Alessandra, et al.
Publicado: (2013)

Impaired HDL2-mediated cholesterol efflux is associated with metabolic syndrome in families with early onset coronary heart disease and low HDL-cholesterol level
por: Paavola, Timo, et al.
Publicado: (2017)

Cholesterol stimulates the lytic activity of Adenylate Cyclase Toxin on lipid membranes by promoting toxin oligomerization and formation of pores with a greater effective size
por: González Bullón, David, et al.
Publicado: (2021)

Adenylate Cyclase Toxin promotes bacterial internalisation into non phagocytic cells
por: Martín, César, et al.
Publicado: (2015)

In Vivo Inflammation Does Not Impair ABCA1-Mediated Cholesterol Efflux Capacity of HDL
por: Franssen, Remco, et al.
Publicado: (2012)

Extra Virgin Olive Oil Polyphenols Promote Cholesterol Efflux and Improve HDL Functionality
por: Berrougui, Hicham, et al.
Publicado: (2015)

Therapeutic FGF19 promotes HDL biogenesis and transhepatic cholesterol efflux to prevent atherosclerosis
por: Zhou, Mei, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o8vu44tlv4482lgst1cilaqqlb